Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedJun 08, 2025
DataAggregated Company Financials
Companies35
  • 7D2.1%
  • 3M-5.4%
  • 1Y5.9%
  • YTD5.3%

The Healthcare industry is up 2.1% in the last week, with Novartis up 3.2%. This means that the industry has gained 5.9% over the past year. As for the next few years, earnings are expected to grow by 14% per annum.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 08 Jun 2025CHF 596.8bCHF 151.8bCHF 22.6b30.8x26.4x3.9x
Tue, 06 May 2025CHF 587.9bCHF 151.4bCHF 22.5b30.4x26.2x3.9x
Thu, 03 Apr 2025CHF 594.4bCHF 154.9bCHF 22.5b29.1x26.4x3.8x
Sat, 01 Mar 2025CHF 629.1bCHF 155.9bCHF 22.5b26.2x28x4x
Mon, 27 Jan 2025CHF 604.1bCHF 152.7bCHF 24.5b31.1x24.6x4x
Wed, 25 Dec 2024CHF 562.0bCHF 152.3bCHF 24.5b28.4x23x3.7x
Fri, 22 Nov 2024CHF 568.4bCHF 151.3bCHF 24.3b29.3x23.4x3.8x
Sun, 20 Oct 2024CHF 618.7bCHF 148.5bCHF 22.6b31.2x27.4x4.2x
Tue, 17 Sep 2024CHF 603.6bCHF 147.0bCHF 22.3b32.6x27.1x4.1x
Thu, 15 Aug 2024CHF 614.7bCHF 148.1bCHF 22.3b31.8x27.6x4.2x
Sat, 13 Jul 2024CHF 595.8bCHF 148.7bCHF 22.7b37.8x26.3x4x
Mon, 10 Jun 2024CHF 572.5bCHF 148.9bCHF 22.7b35.4x25.2x3.8x
Wed, 08 May 2024CHF 537.2bCHF 145.9bCHF 22.8b32.7x23.5x3.7x
Fri, 05 Apr 2024CHF 553.0bCHF 144.4bCHF 22.2b35.7x24.9x3.8x
Sun, 03 Mar 2024CHF 531.8bCHF 143.2bCHF 22.7b36.4x23.5x3.7x
Tue, 30 Jan 2024CHF 546.6bCHF 152.0bCHF 21.9b28x25x3.6x
Thu, 28 Dec 2023CHF 520.3bCHF 150.6bCHF 21.7b26.2x24x3.5x
Sat, 25 Nov 2023CHF 516.0bCHF 153.6bCHF 22.0b24.8x23.4x3.4x
Mon, 23 Oct 2023CHF 505.6bCHF 153.2bCHF 21.6b25.7x23.4x3.3x
Wed, 20 Sep 2023CHF 539.7bCHF 145.0bCHF 21.1b32.6x25.6x3.7x
Fri, 18 Aug 2023CHF 542.4bCHF 143.9bCHF 21.1b31.1x25.7x3.8x
Sun, 16 Jul 2023CHF 553.9bCHF 145.1bCHF 22.0b36.1x25.2x3.8x
Tue, 13 Jun 2023CHF 574.3bCHF 148.0bCHF 22.3b34.3x25.7x3.9x
Thu, 11 May 2023CHF 579.7bCHF 146.9bCHF 22.3b32.7x26x3.9x
Sat, 08 Apr 2023CHF 574.6bCHF 147.3bCHF 22.4b33.1x25.6x3.9x
Mon, 06 Mar 2023CHF 541.3bCHF 148.8bCHF 22.6b31.7x24x3.6x
Wed, 01 Feb 2023CHF 576.0bCHF 149.5bCHF 38.6b31.3x14.9x3.9x
Fri, 30 Dec 2022CHF 562.7bCHF 148.4bCHF 38.0b30.1x14.8x3.8x
Sun, 27 Nov 2022CHF 580.5bCHF 149.8bCHF 38.5b34.4x15.1x3.9x
Tue, 25 Oct 2022CHF 569.2bCHF 153.5bCHF 40.9b26.2x13.9x3.7x
Thu, 22 Sep 2022CHF 557.5bCHF 151.1bCHF 39.9b29.5x14x3.7x
Sat, 20 Aug 2022CHF 594.6bCHF 150.2bCHF 39.7b30.6x15x4x
Mon, 18 Jul 2022CHF 608.3bCHF 149.7bCHF 40.7b33.2x14.9x4.1x
Wed, 15 Jun 2022CHF 570.5bCHF 151.1bCHF 41.3b29.6x13.8x3.8x
Price to Earnings Ratio

13.8x


Total Market Cap: CHF 570.5bTotal Earnings: CHF 41.3bTotal Revenue: CHF 151.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 22.8x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 26.4x which is higher than its 3-year average PE of 22.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 18% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market1.09%
Healthcare2.15%
Pharma2.49%
Medical Equipment1.13%
Life Sciences1.07%
Biotech0.29%
Healthcare Services-0.05%
Healthtech-2.42%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 44.7x.
    • Analysts are expecting annual earnings growth of 19.6%, which is lower than the prior year's growth of 24.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 35% over the next 5 years.
  • This is better than its past earnings decline of 79% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 97.083.2%
+CHF 6.0b		2.2%PE18x
ROG Roche HoldingCHF 268.201.0%
+CHF 2.1b		10.6%PE25.8x
GALD Galderma GroupCHF 115.907.6%
+CHF 1.9b		58.0%PE144.9x
SDZ Sandoz GroupCHF 44.025.5%
+CHF 986.3m		36.8%PS2.2x
ALC AlconCHF 72.021.9%
+CHF 654.3m		-12.3%PE38.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SOON

CHF 256.40

Sonova Holding

7D

-0.5%

1Y

-11.1%

GALD

CHF 115.90

Galderma Group

7D

7.6%

1Y

58.0%

BIOV

CHF 34.60

BioVersys

7D

-3.4%

1Y

n/a

NOVN

CHF 97.08

Novartis

7D

3.2%

1Y

2.2%

SDZ

CHF 44.02

Sandoz Group

7D

5.5%

1Y

36.8%

MED

CHF 77.40

Medartis Holding

7D

-2.6%

1Y

0.3%

LONN

CHF 573.40

Lonza Group

7D

0.7%

1Y

14.6%

Lonza Group AG (VTX:LONN) Not Flying Under The Radar

May 31
Lonza Group AG (VTX:LONN) Not Flying Under The Radar

DESN

CHF 274.50

Dottikon ES Holding

7D

-0.7%

1Y

6.4%

ALC

CHF 72.02

Alcon

7D

1.9%

1Y

-12.3%

STMN

CHF 106.75

Straumann Holding

7D

1.1%

1Y

-8.6%

Here's Why Straumann Holding (VTX:STMN) Can Manage Its Debt Responsibly

May 28
Here's Why Straumann Holding (VTX:STMN) Can Manage Its Debt Responsibly

ROG

CHF 268.20

Roche Holding

7D

1.0%

1Y

10.6%

MOLN

CHF 2.99

Molecular Partners

7D

-6.6%

1Y

-20.2%

BANB

CHF 53.95

Bachem Holding

7D

4.5%

1Y

-31.2%

Bachem Holding AG's (VTX:BANB) Share Price Matching Investor Opinion

May 15
Bachem Holding AG's (VTX:BANB) Share Price Matching Investor Opinion

AEVS

CHF 13.00

Aevis Victoria

7D

-3.7%

1Y

-17.5%

KURN

CHF 24.70

Kuros Biosciences

7D

-5.9%

1Y

138.4%

Kuros Biosciences AG (VTX:KURN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Apr 29
Kuros Biosciences AG (VTX:KURN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

VBSN

CHF 144.50

IVF Hartmann Holding

7D

-3.0%

1Y

11.2%